Sproxil, Inc., announced the establishment of an alliance with Greenlife Pharmaceuticals Limited. Providing protection for the popular anti-malarial drug LONART, the partnership marks Sproxil's first cross-national collaboration between India and Nigeria, allowing Nigerians to verify the authenticity of a crucial anti-malaria drug. To maintain the integrity of the LONART Brand, Greenlife Pharmaceuticals and LONART manufacturer Bliss GVS Pharma have instituted a Mobile Authentication Service (MAS) to provide customers a way to verify the authenticity of their product at the point of purchase. Powered by Sproxil advanced technology, the same anti-counterfeiting services were launched by NAFDAC in Lagos last year and continue to prove successful in creating unsafe harbours for counterfeiters. Sproxil's Mobile Product Authentication (MPA) technology capitalises on technologies that already exist and are readily accessible and easily understood by all levels of society - namely cellular phone SMS capabilities and scratch-off lottery-style labels. The company's services allow end consumers to verify with a simple free text message that they are not purchasing counterfeit medication.